Global Primary Hepatocytes Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Primary Hepatocytes Industry Forecast” looks at past sales and reviews total world Primary Hepatocytes sales in 2022, providing a comprehensive analysis by region and market sector of projected Primary Hepatocytes sales for 2023 through 2029. With Primary Hepatocytes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Primary Hepatocytes industry.
This Insight Report provides a comprehensive analysis of the global Primary Hepatocytes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Primary Hepatocytes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Primary Hepatocytes market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Primary Hepatocytes and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Primary Hepatocytes.
The global Primary Hepatocytes market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Primary Hepatocytes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Primary Hepatocytes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Primary Hepatocytes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Primary Hepatocytes players cover Thermo Fisher Scientific, Inc., Merck KGaA, Lonza, Cell Biologics, Inc., PromoCell GmbH, HemaCare Corporation, ZenBio, Inc., STEMCELL Technologies, Inc. and Corning Incorporated, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Primary Hepatocytes market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Primary Hepatocytes market?
What factors are driving Primary Hepatocytes market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Primary Hepatocytes market opportunities vary by end market size?
How does Primary Hepatocytes break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Primary Hepatocytes Industry Forecast” looks at past sales and reviews total world Primary Hepatocytes sales in 2022, providing a comprehensive analysis by region and market sector of projected Primary Hepatocytes sales for 2023 through 2029. With Primary Hepatocytes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Primary Hepatocytes industry.
This Insight Report provides a comprehensive analysis of the global Primary Hepatocytes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Primary Hepatocytes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Primary Hepatocytes market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Primary Hepatocytes and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Primary Hepatocytes.
The global Primary Hepatocytes market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Primary Hepatocytes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Primary Hepatocytes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Primary Hepatocytes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Primary Hepatocytes players cover Thermo Fisher Scientific, Inc., Merck KGaA, Lonza, Cell Biologics, Inc., PromoCell GmbH, HemaCare Corporation, ZenBio, Inc., STEMCELL Technologies, Inc. and Corning Incorporated, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Primary Hepatocytes market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Human Primary Cells
- Animal Primary Cells
- Life Science Research Companies
- Research Institutes
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Lonza
- Cell Biologics, Inc.
- PromoCell GmbH
- HemaCare Corporation
- ZenBio, Inc.
- STEMCELL Technologies, Inc.
- Corning Incorporated
- AllCells
- Axol Bioscience Ltd.
- iXCells Biotechnologies
- Neuromics
- StemExpress
- BioIVT
- ScienCell Research Laboratories, Inc.
- PPA Research Group, Inc.
- Creative Bioarray
- BPS Bioscience, Inc.
- Epithelix S?rl
- ReachBio LLC
- AcceGen
- Sekisui XenoTech, LLC
- Biopredic International
What is the 10-year outlook for the global Primary Hepatocytes market?
What factors are driving Primary Hepatocytes market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Primary Hepatocytes market opportunities vary by end market size?
How does Primary Hepatocytes break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Primary Hepatocytes Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Primary Hepatocytes by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Primary Hepatocytes by Country/Region, 2018, 2022 & 2029
2.2 Primary Hepatocytes Segment by Type
2.2.1 Human Primary Cells
2.2.2 Animal Primary Cells
2.3 Primary Hepatocytes Sales by Type
2.3.1 Global Primary Hepatocytes Sales Market Share by Type (2018-2023)
2.3.2 Global Primary Hepatocytes Revenue and Market Share by Type (2018-2023)
2.3.3 Global Primary Hepatocytes Sale Price by Type (2018-2023)
2.4 Primary Hepatocytes Segment by Application
2.4.1 Life Science Research Companies
2.4.2 Research Institutes
2.4.3 Others
2.5 Primary Hepatocytes Sales by Application
2.5.1 Global Primary Hepatocytes Sale Market Share by Application (2018-2023)
2.5.2 Global Primary Hepatocytes Revenue and Market Share by Application (2018-2023)
2.5.3 Global Primary Hepatocytes Sale Price by Application (2018-2023)
3 GLOBAL PRIMARY HEPATOCYTES BY COMPANY
3.1 Global Primary Hepatocytes Breakdown Data by Company
3.1.1 Global Primary Hepatocytes Annual Sales by Company (2018-2023)
3.1.2 Global Primary Hepatocytes Sales Market Share by Company (2018-2023)
3.2 Global Primary Hepatocytes Annual Revenue by Company (2018-2023)
3.2.1 Global Primary Hepatocytes Revenue by Company (2018-2023)
3.2.2 Global Primary Hepatocytes Revenue Market Share by Company (2018-2023)
3.3 Global Primary Hepatocytes Sale Price by Company
3.4 Key Manufacturers Primary Hepatocytes Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Primary Hepatocytes Product Location Distribution
3.4.2 Players Primary Hepatocytes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PRIMARY HEPATOCYTES BY GEOGRAPHIC REGION
4.1 World Historic Primary Hepatocytes Market Size by Geographic Region (2018-2023)
4.1.1 Global Primary Hepatocytes Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Primary Hepatocytes Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Primary Hepatocytes Market Size by Country/Region (2018-2023)
4.2.1 Global Primary Hepatocytes Annual Sales by Country/Region (2018-2023)
4.2.2 Global Primary Hepatocytes Annual Revenue by Country/Region (2018-2023)
4.3 Americas Primary Hepatocytes Sales Growth
4.4 APAC Primary Hepatocytes Sales Growth
4.5 Europe Primary Hepatocytes Sales Growth
4.6 Middle East & Africa Primary Hepatocytes Sales Growth
5 AMERICAS
5.1 Americas Primary Hepatocytes Sales by Country
5.1.1 Americas Primary Hepatocytes Sales by Country (2018-2023)
5.1.2 Americas Primary Hepatocytes Revenue by Country (2018-2023)
5.2 Americas Primary Hepatocytes Sales by Type
5.3 Americas Primary Hepatocytes Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Primary Hepatocytes Sales by Region
6.1.1 APAC Primary Hepatocytes Sales by Region (2018-2023)
6.1.2 APAC Primary Hepatocytes Revenue by Region (2018-2023)
6.2 APAC Primary Hepatocytes Sales by Type
6.3 APAC Primary Hepatocytes Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Primary Hepatocytes by Country
7.1.1 Europe Primary Hepatocytes Sales by Country (2018-2023)
7.1.2 Europe Primary Hepatocytes Revenue by Country (2018-2023)
7.2 Europe Primary Hepatocytes Sales by Type
7.3 Europe Primary Hepatocytes Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Primary Hepatocytes by Country
8.1.1 Middle East & Africa Primary Hepatocytes Sales by Country (2018-2023)
8.1.2 Middle East & Africa Primary Hepatocytes Revenue by Country (2018-2023)
8.2 Middle East & Africa Primary Hepatocytes Sales by Type
8.3 Middle East & Africa Primary Hepatocytes Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Primary Hepatocytes
10.3 Manufacturing Process Analysis of Primary Hepatocytes
10.4 Industry Chain Structure of Primary Hepatocytes
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Primary Hepatocytes Distributors
11.3 Primary Hepatocytes Customer
12 WORLD FORECAST REVIEW FOR PRIMARY HEPATOCYTES BY GEOGRAPHIC REGION
12.1 Global Primary Hepatocytes Market Size Forecast by Region
12.1.1 Global Primary Hepatocytes Forecast by Region (2024-2029)
12.1.2 Global Primary Hepatocytes Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Primary Hepatocytes Forecast by Type
12.7 Global Primary Hepatocytes Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Thermo Fisher Scientific, Inc.
13.1.1 Thermo Fisher Scientific, Inc. Company Information
13.1.2 Thermo Fisher Scientific, Inc. Primary Hepatocytes Product Portfolios and Specifications
13.1.3 Thermo Fisher Scientific, Inc. Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Thermo Fisher Scientific, Inc. Main Business Overview
13.1.5 Thermo Fisher Scientific, Inc. Latest Developments
13.2 Merck KGaA
13.2.1 Merck KGaA Company Information
13.2.2 Merck KGaA Primary Hepatocytes Product Portfolios and Specifications
13.2.3 Merck KGaA Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck KGaA Main Business Overview
13.2.5 Merck KGaA Latest Developments
13.3 Lonza
13.3.1 Lonza Company Information
13.3.2 Lonza Primary Hepatocytes Product Portfolios and Specifications
13.3.3 Lonza Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Lonza Main Business Overview
13.3.5 Lonza Latest Developments
13.4 Cell Biologics, Inc.
13.4.1 Cell Biologics, Inc. Company Information
13.4.2 Cell Biologics, Inc. Primary Hepatocytes Product Portfolios and Specifications
13.4.3 Cell Biologics, Inc. Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Cell Biologics, Inc. Main Business Overview
13.4.5 Cell Biologics, Inc. Latest Developments
13.5 PromoCell GmbH
13.5.1 PromoCell GmbH Company Information
13.5.2 PromoCell GmbH Primary Hepatocytes Product Portfolios and Specifications
13.5.3 PromoCell GmbH Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 PromoCell GmbH Main Business Overview
13.5.5 PromoCell GmbH Latest Developments
13.6 HemaCare Corporation
13.6.1 HemaCare Corporation Company Information
13.6.2 HemaCare Corporation Primary Hepatocytes Product Portfolios and Specifications
13.6.3 HemaCare Corporation Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 HemaCare Corporation Main Business Overview
13.6.5 HemaCare Corporation Latest Developments
13.7 ZenBio, Inc.
13.7.1 ZenBio, Inc. Company Information
13.7.2 ZenBio, Inc. Primary Hepatocytes Product Portfolios and Specifications
13.7.3 ZenBio, Inc. Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 ZenBio, Inc. Main Business Overview
13.7.5 ZenBio, Inc. Latest Developments
13.8 STEMCELL Technologies, Inc.
13.8.1 STEMCELL Technologies, Inc. Company Information
13.8.2 STEMCELL Technologies, Inc. Primary Hepatocytes Product Portfolios and Specifications
13.8.3 STEMCELL Technologies, Inc. Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 STEMCELL Technologies, Inc. Main Business Overview
13.8.5 STEMCELL Technologies, Inc. Latest Developments
13.9 Corning Incorporated
13.9.1 Corning Incorporated Company Information
13.9.2 Corning Incorporated Primary Hepatocytes Product Portfolios and Specifications
13.9.3 Corning Incorporated Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Corning Incorporated Main Business Overview
13.9.5 Corning Incorporated Latest Developments
13.10 AllCells
13.10.1 AllCells Company Information
13.10.2 AllCells Primary Hepatocytes Product Portfolios and Specifications
13.10.3 AllCells Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 AllCells Main Business Overview
13.10.5 AllCells Latest Developments
13.11 Axol Bioscience Ltd.
13.11.1 Axol Bioscience Ltd. Company Information
13.11.2 Axol Bioscience Ltd. Primary Hepatocytes Product Portfolios and Specifications
13.11.3 Axol Bioscience Ltd. Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Axol Bioscience Ltd. Main Business Overview
13.11.5 Axol Bioscience Ltd. Latest Developments
13.12 iXCells Biotechnologies
13.12.1 iXCells Biotechnologies Company Information
13.12.2 iXCells Biotechnologies Primary Hepatocytes Product Portfolios and Specifications
13.12.3 iXCells Biotechnologies Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 iXCells Biotechnologies Main Business Overview
13.12.5 iXCells Biotechnologies Latest Developments
13.13 Neuromics
13.13.1 Neuromics Company Information
13.13.2 Neuromics Primary Hepatocytes Product Portfolios and Specifications
13.13.3 Neuromics Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Neuromics Main Business Overview
13.13.5 Neuromics Latest Developments
13.14 StemExpress
13.14.1 StemExpress Company Information
13.14.2 StemExpress Primary Hepatocytes Product Portfolios and Specifications
13.14.3 StemExpress Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 StemExpress Main Business Overview
13.14.5 StemExpress Latest Developments
13.15 BioIVT
13.15.1 BioIVT Company Information
13.15.2 BioIVT Primary Hepatocytes Product Portfolios and Specifications
13.15.3 BioIVT Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 BioIVT Main Business Overview
13.15.5 BioIVT Latest Developments
13.16 ScienCell Research Laboratories, Inc.
13.16.1 ScienCell Research Laboratories, Inc. Company Information
13.16.2 ScienCell Research Laboratories, Inc. Primary Hepatocytes Product Portfolios and Specifications
13.16.3 ScienCell Research Laboratories, Inc. Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 ScienCell Research Laboratories, Inc. Main Business Overview
13.16.5 ScienCell Research Laboratories, Inc. Latest Developments
13.17 PPA Research Group, Inc.
13.17.1 PPA Research Group, Inc. Company Information
13.17.2 PPA Research Group, Inc. Primary Hepatocytes Product Portfolios and Specifications
13.17.3 PPA Research Group, Inc. Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 PPA Research Group, Inc. Main Business Overview
13.17.5 PPA Research Group, Inc. Latest Developments
13.18 Creative Bioarray
13.18.1 Creative Bioarray Company Information
13.18.2 Creative Bioarray Primary Hepatocytes Product Portfolios and Specifications
13.18.3 Creative Bioarray Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Creative Bioarray Main Business Overview
13.18.5 Creative Bioarray Latest Developments
13.19 BPS Bioscience, Inc.
13.19.1 BPS Bioscience, Inc. Company Information
13.19.2 BPS Bioscience, Inc. Primary Hepatocytes Product Portfolios and Specifications
13.19.3 BPS Bioscience, Inc. Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 BPS Bioscience, Inc. Main Business Overview
13.19.5 BPS Bioscience, Inc. Latest Developments
13.20 Epithelix S?rl
13.20.1 Epithelix S?rl Company Information
13.20.2 Epithelix S?rl Primary Hepatocytes Product Portfolios and Specifications
13.20.3 Epithelix S?rl Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Epithelix S?rl Main Business Overview
13.20.5 Epithelix S?rl Latest Developments
13.21 ReachBio LLC
13.21.1 ReachBio LLC Company Information
13.21.2 ReachBio LLC Primary Hepatocytes Product Portfolios and Specifications
13.21.3 ReachBio LLC Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 ReachBio LLC Main Business Overview
13.21.5 ReachBio LLC Latest Developments
13.22 AcceGen
13.22.1 AcceGen Company Information
13.22.2 AcceGen Primary Hepatocytes Product Portfolios and Specifications
13.22.3 AcceGen Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 AcceGen Main Business Overview
13.22.5 AcceGen Latest Developments
13.23 Sekisui XenoTech, LLC
13.23.1 Sekisui XenoTech, LLC Company Information
13.23.2 Sekisui XenoTech, LLC Primary Hepatocytes Product Portfolios and Specifications
13.23.3 Sekisui XenoTech, LLC Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 Sekisui XenoTech, LLC Main Business Overview
13.23.5 Sekisui XenoTech, LLC Latest Developments
13.24 Biopredic International
13.24.1 Biopredic International Company Information
13.24.2 Biopredic International Primary Hepatocytes Product Portfolios and Specifications
13.24.3 Biopredic International Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.24.4 Biopredic International Main Business Overview
13.24.5 Biopredic International Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Primary Hepatocytes Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Primary Hepatocytes by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Primary Hepatocytes by Country/Region, 2018, 2022 & 2029
2.2 Primary Hepatocytes Segment by Type
2.2.1 Human Primary Cells
2.2.2 Animal Primary Cells
2.3 Primary Hepatocytes Sales by Type
2.3.1 Global Primary Hepatocytes Sales Market Share by Type (2018-2023)
2.3.2 Global Primary Hepatocytes Revenue and Market Share by Type (2018-2023)
2.3.3 Global Primary Hepatocytes Sale Price by Type (2018-2023)
2.4 Primary Hepatocytes Segment by Application
2.4.1 Life Science Research Companies
2.4.2 Research Institutes
2.4.3 Others
2.5 Primary Hepatocytes Sales by Application
2.5.1 Global Primary Hepatocytes Sale Market Share by Application (2018-2023)
2.5.2 Global Primary Hepatocytes Revenue and Market Share by Application (2018-2023)
2.5.3 Global Primary Hepatocytes Sale Price by Application (2018-2023)
3 GLOBAL PRIMARY HEPATOCYTES BY COMPANY
3.1 Global Primary Hepatocytes Breakdown Data by Company
3.1.1 Global Primary Hepatocytes Annual Sales by Company (2018-2023)
3.1.2 Global Primary Hepatocytes Sales Market Share by Company (2018-2023)
3.2 Global Primary Hepatocytes Annual Revenue by Company (2018-2023)
3.2.1 Global Primary Hepatocytes Revenue by Company (2018-2023)
3.2.2 Global Primary Hepatocytes Revenue Market Share by Company (2018-2023)
3.3 Global Primary Hepatocytes Sale Price by Company
3.4 Key Manufacturers Primary Hepatocytes Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Primary Hepatocytes Product Location Distribution
3.4.2 Players Primary Hepatocytes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PRIMARY HEPATOCYTES BY GEOGRAPHIC REGION
4.1 World Historic Primary Hepatocytes Market Size by Geographic Region (2018-2023)
4.1.1 Global Primary Hepatocytes Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Primary Hepatocytes Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Primary Hepatocytes Market Size by Country/Region (2018-2023)
4.2.1 Global Primary Hepatocytes Annual Sales by Country/Region (2018-2023)
4.2.2 Global Primary Hepatocytes Annual Revenue by Country/Region (2018-2023)
4.3 Americas Primary Hepatocytes Sales Growth
4.4 APAC Primary Hepatocytes Sales Growth
4.5 Europe Primary Hepatocytes Sales Growth
4.6 Middle East & Africa Primary Hepatocytes Sales Growth
5 AMERICAS
5.1 Americas Primary Hepatocytes Sales by Country
5.1.1 Americas Primary Hepatocytes Sales by Country (2018-2023)
5.1.2 Americas Primary Hepatocytes Revenue by Country (2018-2023)
5.2 Americas Primary Hepatocytes Sales by Type
5.3 Americas Primary Hepatocytes Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Primary Hepatocytes Sales by Region
6.1.1 APAC Primary Hepatocytes Sales by Region (2018-2023)
6.1.2 APAC Primary Hepatocytes Revenue by Region (2018-2023)
6.2 APAC Primary Hepatocytes Sales by Type
6.3 APAC Primary Hepatocytes Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Primary Hepatocytes by Country
7.1.1 Europe Primary Hepatocytes Sales by Country (2018-2023)
7.1.2 Europe Primary Hepatocytes Revenue by Country (2018-2023)
7.2 Europe Primary Hepatocytes Sales by Type
7.3 Europe Primary Hepatocytes Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Primary Hepatocytes by Country
8.1.1 Middle East & Africa Primary Hepatocytes Sales by Country (2018-2023)
8.1.2 Middle East & Africa Primary Hepatocytes Revenue by Country (2018-2023)
8.2 Middle East & Africa Primary Hepatocytes Sales by Type
8.3 Middle East & Africa Primary Hepatocytes Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Primary Hepatocytes
10.3 Manufacturing Process Analysis of Primary Hepatocytes
10.4 Industry Chain Structure of Primary Hepatocytes
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Primary Hepatocytes Distributors
11.3 Primary Hepatocytes Customer
12 WORLD FORECAST REVIEW FOR PRIMARY HEPATOCYTES BY GEOGRAPHIC REGION
12.1 Global Primary Hepatocytes Market Size Forecast by Region
12.1.1 Global Primary Hepatocytes Forecast by Region (2024-2029)
12.1.2 Global Primary Hepatocytes Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Primary Hepatocytes Forecast by Type
12.7 Global Primary Hepatocytes Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Thermo Fisher Scientific, Inc.
13.1.1 Thermo Fisher Scientific, Inc. Company Information
13.1.2 Thermo Fisher Scientific, Inc. Primary Hepatocytes Product Portfolios and Specifications
13.1.3 Thermo Fisher Scientific, Inc. Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Thermo Fisher Scientific, Inc. Main Business Overview
13.1.5 Thermo Fisher Scientific, Inc. Latest Developments
13.2 Merck KGaA
13.2.1 Merck KGaA Company Information
13.2.2 Merck KGaA Primary Hepatocytes Product Portfolios and Specifications
13.2.3 Merck KGaA Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck KGaA Main Business Overview
13.2.5 Merck KGaA Latest Developments
13.3 Lonza
13.3.1 Lonza Company Information
13.3.2 Lonza Primary Hepatocytes Product Portfolios and Specifications
13.3.3 Lonza Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Lonza Main Business Overview
13.3.5 Lonza Latest Developments
13.4 Cell Biologics, Inc.
13.4.1 Cell Biologics, Inc. Company Information
13.4.2 Cell Biologics, Inc. Primary Hepatocytes Product Portfolios and Specifications
13.4.3 Cell Biologics, Inc. Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Cell Biologics, Inc. Main Business Overview
13.4.5 Cell Biologics, Inc. Latest Developments
13.5 PromoCell GmbH
13.5.1 PromoCell GmbH Company Information
13.5.2 PromoCell GmbH Primary Hepatocytes Product Portfolios and Specifications
13.5.3 PromoCell GmbH Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 PromoCell GmbH Main Business Overview
13.5.5 PromoCell GmbH Latest Developments
13.6 HemaCare Corporation
13.6.1 HemaCare Corporation Company Information
13.6.2 HemaCare Corporation Primary Hepatocytes Product Portfolios and Specifications
13.6.3 HemaCare Corporation Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 HemaCare Corporation Main Business Overview
13.6.5 HemaCare Corporation Latest Developments
13.7 ZenBio, Inc.
13.7.1 ZenBio, Inc. Company Information
13.7.2 ZenBio, Inc. Primary Hepatocytes Product Portfolios and Specifications
13.7.3 ZenBio, Inc. Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 ZenBio, Inc. Main Business Overview
13.7.5 ZenBio, Inc. Latest Developments
13.8 STEMCELL Technologies, Inc.
13.8.1 STEMCELL Technologies, Inc. Company Information
13.8.2 STEMCELL Technologies, Inc. Primary Hepatocytes Product Portfolios and Specifications
13.8.3 STEMCELL Technologies, Inc. Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 STEMCELL Technologies, Inc. Main Business Overview
13.8.5 STEMCELL Technologies, Inc. Latest Developments
13.9 Corning Incorporated
13.9.1 Corning Incorporated Company Information
13.9.2 Corning Incorporated Primary Hepatocytes Product Portfolios and Specifications
13.9.3 Corning Incorporated Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Corning Incorporated Main Business Overview
13.9.5 Corning Incorporated Latest Developments
13.10 AllCells
13.10.1 AllCells Company Information
13.10.2 AllCells Primary Hepatocytes Product Portfolios and Specifications
13.10.3 AllCells Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 AllCells Main Business Overview
13.10.5 AllCells Latest Developments
13.11 Axol Bioscience Ltd.
13.11.1 Axol Bioscience Ltd. Company Information
13.11.2 Axol Bioscience Ltd. Primary Hepatocytes Product Portfolios and Specifications
13.11.3 Axol Bioscience Ltd. Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Axol Bioscience Ltd. Main Business Overview
13.11.5 Axol Bioscience Ltd. Latest Developments
13.12 iXCells Biotechnologies
13.12.1 iXCells Biotechnologies Company Information
13.12.2 iXCells Biotechnologies Primary Hepatocytes Product Portfolios and Specifications
13.12.3 iXCells Biotechnologies Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 iXCells Biotechnologies Main Business Overview
13.12.5 iXCells Biotechnologies Latest Developments
13.13 Neuromics
13.13.1 Neuromics Company Information
13.13.2 Neuromics Primary Hepatocytes Product Portfolios and Specifications
13.13.3 Neuromics Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Neuromics Main Business Overview
13.13.5 Neuromics Latest Developments
13.14 StemExpress
13.14.1 StemExpress Company Information
13.14.2 StemExpress Primary Hepatocytes Product Portfolios and Specifications
13.14.3 StemExpress Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 StemExpress Main Business Overview
13.14.5 StemExpress Latest Developments
13.15 BioIVT
13.15.1 BioIVT Company Information
13.15.2 BioIVT Primary Hepatocytes Product Portfolios and Specifications
13.15.3 BioIVT Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 BioIVT Main Business Overview
13.15.5 BioIVT Latest Developments
13.16 ScienCell Research Laboratories, Inc.
13.16.1 ScienCell Research Laboratories, Inc. Company Information
13.16.2 ScienCell Research Laboratories, Inc. Primary Hepatocytes Product Portfolios and Specifications
13.16.3 ScienCell Research Laboratories, Inc. Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 ScienCell Research Laboratories, Inc. Main Business Overview
13.16.5 ScienCell Research Laboratories, Inc. Latest Developments
13.17 PPA Research Group, Inc.
13.17.1 PPA Research Group, Inc. Company Information
13.17.2 PPA Research Group, Inc. Primary Hepatocytes Product Portfolios and Specifications
13.17.3 PPA Research Group, Inc. Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 PPA Research Group, Inc. Main Business Overview
13.17.5 PPA Research Group, Inc. Latest Developments
13.18 Creative Bioarray
13.18.1 Creative Bioarray Company Information
13.18.2 Creative Bioarray Primary Hepatocytes Product Portfolios and Specifications
13.18.3 Creative Bioarray Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Creative Bioarray Main Business Overview
13.18.5 Creative Bioarray Latest Developments
13.19 BPS Bioscience, Inc.
13.19.1 BPS Bioscience, Inc. Company Information
13.19.2 BPS Bioscience, Inc. Primary Hepatocytes Product Portfolios and Specifications
13.19.3 BPS Bioscience, Inc. Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 BPS Bioscience, Inc. Main Business Overview
13.19.5 BPS Bioscience, Inc. Latest Developments
13.20 Epithelix S?rl
13.20.1 Epithelix S?rl Company Information
13.20.2 Epithelix S?rl Primary Hepatocytes Product Portfolios and Specifications
13.20.3 Epithelix S?rl Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Epithelix S?rl Main Business Overview
13.20.5 Epithelix S?rl Latest Developments
13.21 ReachBio LLC
13.21.1 ReachBio LLC Company Information
13.21.2 ReachBio LLC Primary Hepatocytes Product Portfolios and Specifications
13.21.3 ReachBio LLC Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 ReachBio LLC Main Business Overview
13.21.5 ReachBio LLC Latest Developments
13.22 AcceGen
13.22.1 AcceGen Company Information
13.22.2 AcceGen Primary Hepatocytes Product Portfolios and Specifications
13.22.3 AcceGen Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 AcceGen Main Business Overview
13.22.5 AcceGen Latest Developments
13.23 Sekisui XenoTech, LLC
13.23.1 Sekisui XenoTech, LLC Company Information
13.23.2 Sekisui XenoTech, LLC Primary Hepatocytes Product Portfolios and Specifications
13.23.3 Sekisui XenoTech, LLC Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 Sekisui XenoTech, LLC Main Business Overview
13.23.5 Sekisui XenoTech, LLC Latest Developments
13.24 Biopredic International
13.24.1 Biopredic International Company Information
13.24.2 Biopredic International Primary Hepatocytes Product Portfolios and Specifications
13.24.3 Biopredic International Primary Hepatocytes Sales, Revenue, Price and Gross Margin (2018-2023)
13.24.4 Biopredic International Main Business Overview
13.24.5 Biopredic International Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Primary Hepatocytes Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Primary Hepatocytes Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Human Primary Cells
Table 4. Major Players of Animal Primary Cells
Table 5. Global Primary Hepatocytes Sales by Type (2018-2023) & (K MT)
Table 6. Global Primary Hepatocytes Sales Market Share by Type (2018-2023)
Table 7. Global Primary Hepatocytes Revenue by Type (2018-2023) & ($ million)
Table 8. Global Primary Hepatocytes Revenue Market Share by Type (2018-2023)
Table 9. Global Primary Hepatocytes Sale Price by Type (2018-2023) & (USD/MT)
Table 10. Global Primary Hepatocytes Sales by Application (2018-2023) & (K MT)
Table 11. Global Primary Hepatocytes Sales Market Share by Application (2018-2023)
Table 12. Global Primary Hepatocytes Revenue by Application (2018-2023)
Table 13. Global Primary Hepatocytes Revenue Market Share by Application (2018-2023)
Table 14. Global Primary Hepatocytes Sale Price by Application (2018-2023) & (USD/MT)
Table 15. Global Primary Hepatocytes Sales by Company (2018-2023) & (K MT)
Table 16. Global Primary Hepatocytes Sales Market Share by Company (2018-2023)
Table 17. Global Primary Hepatocytes Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Primary Hepatocytes Revenue Market Share by Company (2018-2023)
Table 19. Global Primary Hepatocytes Sale Price by Company (2018-2023) & (USD/MT)
Table 20. Key Manufacturers Primary Hepatocytes Producing Area Distribution and Sales Area
Table 21. Players Primary Hepatocytes Products Offered
Table 22. Primary Hepatocytes Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Primary Hepatocytes Sales by Geographic Region (2018-2023) & (K MT)
Table 26. Global Primary Hepatocytes Sales Market Share Geographic Region (2018-2023)
Table 27. Global Primary Hepatocytes Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Primary Hepatocytes Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Primary Hepatocytes Sales by Country/Region (2018-2023) & (K MT)
Table 30. Global Primary Hepatocytes Sales Market Share by Country/Region (2018-2023)
Table 31. Global Primary Hepatocytes Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Primary Hepatocytes Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Primary Hepatocytes Sales by Country (2018-2023) & (K MT)
Table 34. Americas Primary Hepatocytes Sales Market Share by Country (2018-2023)
Table 35. Americas Primary Hepatocytes Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Primary Hepatocytes Revenue Market Share by Country (2018-2023)
Table 37. Americas Primary Hepatocytes Sales by Type (2018-2023) & (K MT)
Table 38. Americas Primary Hepatocytes Sales by Application (2018-2023) & (K MT)
Table 39. APAC Primary Hepatocytes Sales by Region (2018-2023) & (K MT)
Table 40. APAC Primary Hepatocytes Sales Market Share by Region (2018-2023)
Table 41. APAC Primary Hepatocytes Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Primary Hepatocytes Revenue Market Share by Region (2018-2023)
Table 43. APAC Primary Hepatocytes Sales by Type (2018-2023) & (K MT)
Table 44. APAC Primary Hepatocytes Sales by Application (2018-2023) & (K MT)
Table 45. Europe Primary Hepatocytes Sales by Country (2018-2023) & (K MT)
Table 46. Europe Primary Hepatocytes Sales Market Share by Country (2018-2023)
Table 47. Europe Primary Hepatocytes Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Primary Hepatocytes Revenue Market Share by Country (2018-2023)
Table 49. Europe Primary Hepatocytes Sales by Type (2018-2023) & (K MT)
Table 50. Europe Primary Hepatocytes Sales by Application (2018-2023) & (K MT)
Table 51. Middle East & Africa Primary Hepatocytes Sales by Country (2018-2023) & (K MT)
Table 52. Middle East & Africa Primary Hepatocytes Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Primary Hepatocytes Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Primary Hepatocytes Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Primary Hepatocytes Sales by Type (2018-2023) & (K MT)
Table 56. Middle East & Africa Primary Hepatocytes Sales by Application (2018-2023) & (K MT)
Table 57. Key Market Drivers & Growth Opportunities of Primary Hepatocytes
Table 58. Key Market Challenges & Risks of Primary Hepatocytes
Table 59. Key Industry Trends of Primary Hepatocytes
Table 60. Primary Hepatocytes Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Primary Hepatocytes Distributors List
Table 63. Primary Hepatocytes Customer List
Table 64. Global Primary Hepatocytes Sales Forecast by Region (2024-2029) & (K MT)
Table 65. Global Primary Hepatocytes Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Primary Hepatocytes Sales Forecast by Country (2024-2029) & (K MT)
Table 67. Americas Primary Hepatocytes Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Primary Hepatocytes Sales Forecast by Region (2024-2029) & (K MT)
Table 69. APAC Primary Hepatocytes Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Primary Hepatocytes Sales Forecast by Country (2024-2029) & (K MT)
Table 71. Europe Primary Hepatocytes Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Primary Hepatocytes Sales Forecast by Country (2024-2029) & (K MT)
Table 73. Middle East & Africa Primary Hepatocytes Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Primary Hepatocytes Sales Forecast by Type (2024-2029) & (K MT)
Table 75. Global Primary Hepatocytes Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Primary Hepatocytes Sales Forecast by Application (2024-2029) & (K MT)
Table 77. Global Primary Hepatocytes Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Thermo Fisher Scientific, Inc. Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 79. Thermo Fisher Scientific, Inc. Primary Hepatocytes Product Portfolios and Specifications
Table 80. Thermo Fisher Scientific, Inc. Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 81. Thermo Fisher Scientific, Inc. Main Business
Table 82. Thermo Fisher Scientific, Inc. Latest Developments
Table 83. Merck KGaA Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck KGaA Primary Hepatocytes Product Portfolios and Specifications
Table 85. Merck KGaA Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 86. Merck KGaA Main Business
Table 87. Merck KGaA Latest Developments
Table 88. Lonza Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 89. Lonza Primary Hepatocytes Product Portfolios and Specifications
Table 90. Lonza Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 91. Lonza Main Business
Table 92. Lonza Latest Developments
Table 93. Cell Biologics, Inc. Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 94. Cell Biologics, Inc. Primary Hepatocytes Product Portfolios and Specifications
Table 95. Cell Biologics, Inc. Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 96. Cell Biologics, Inc. Main Business
Table 97. Cell Biologics, Inc. Latest Developments
Table 98. PromoCell GmbH Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 99. PromoCell GmbH Primary Hepatocytes Product Portfolios and Specifications
Table 100. PromoCell GmbH Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 101. PromoCell GmbH Main Business
Table 102. PromoCell GmbH Latest Developments
Table 103. HemaCare Corporation Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 104. HemaCare Corporation Primary Hepatocytes Product Portfolios and Specifications
Table 105. HemaCare Corporation Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 106. HemaCare Corporation Main Business
Table 107. HemaCare Corporation Latest Developments
Table 108. ZenBio, Inc. Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 109. ZenBio, Inc. Primary Hepatocytes Product Portfolios and Specifications
Table 110. ZenBio, Inc. Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 111. ZenBio, Inc. Main Business
Table 112. ZenBio, Inc. Latest Developments
Table 113. STEMCELL Technologies, Inc. Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 114. STEMCELL Technologies, Inc. Primary Hepatocytes Product Portfolios and Specifications
Table 115. STEMCELL Technologies, Inc. Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 116. STEMCELL Technologies, Inc. Main Business
Table 117. STEMCELL Technologies, Inc. Latest Developments
Table 118. Corning Incorporated Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 119. Corning Incorporated Primary Hepatocytes Product Portfolios and Specifications
Table 120. Corning Incorporated Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 121. Corning Incorporated Main Business
Table 122. Corning Incorporated Latest Developments
Table 123. AllCells Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 124. AllCells Primary Hepatocytes Product Portfolios and Specifications
Table 125. AllCells Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 126. AllCells Main Business
Table 127. AllCells Latest Developments
Table 128. Axol Bioscience Ltd. Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 129. Axol Bioscience Ltd. Primary Hepatocytes Product Portfolios and Specifications
Table 130. Axol Bioscience Ltd. Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 131. Axol Bioscience Ltd. Main Business
Table 132. Axol Bioscience Ltd. Latest Developments
Table 133. iXCells Biotechnologies Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 134. iXCells Biotechnologies Primary Hepatocytes Product Portfolios and Specifications
Table 135. iXCells Biotechnologies Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 136. iXCells Biotechnologies Main Business
Table 137. iXCells Biotechnologies Latest Developments
Table 138. Neuromics Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 139. Neuromics Primary Hepatocytes Product Portfolios and Specifications
Table 140. Neuromics Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 141. Neuromics Main Business
Table 142. Neuromics Latest Developments
Table 143. StemExpress Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 144. StemExpress Primary Hepatocytes Product Portfolios and Specifications
Table 145. StemExpress Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 146. StemExpress Main Business
Table 147. StemExpress Latest Developments
Table 148. BioIVT Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 149. BioIVT Primary Hepatocytes Product Portfolios and Specifications
Table 150. BioIVT Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 151. BioIVT Main Business
Table 152. BioIVT Latest Developments
Table 153. ScienCell Research Laboratories, Inc. Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 154. ScienCell Research Laboratories, Inc. Primary Hepatocytes Product Portfolios and Specifications
Table 155. ScienCell Research Laboratories, Inc. Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 156. ScienCell Research Laboratories, Inc. Main Business
Table 157. ScienCell Research Laboratories, Inc. Latest Developments
Table 158. PPA Research Group, Inc. Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 159. PPA Research Group, Inc. Primary Hepatocytes Product Portfolios and Specifications
Table 160. PPA Research Group, Inc. Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 161. PPA Research Group, Inc. Main Business
Table 162. PPA Research Group, Inc. Latest Developments
Table 163. Creative Bioarray Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 164. Creative Bioarray Primary Hepatocytes Product Portfolios and Specifications
Table 165. Creative Bioarray Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 166. Creative Bioarray Main Business
Table 167. Creative Bioarray Latest Developments
Table 168. BPS Bioscience, Inc. Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 169. BPS Bioscience, Inc. Primary Hepatocytes Product Portfolios and Specifications
Table 170. BPS Bioscience, Inc. Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 171. BPS Bioscience, Inc. Main Business
Table 172. BPS Bioscience, Inc. Latest Developments
Table 173. Epithelix S?rl Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 174. Epithelix S?rl Primary Hepatocytes Product Portfolios and Specifications
Table 175. Epithelix S?rl Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 176. Epithelix S?rl Main Business
Table 177. Epithelix S?rl Latest Developments
Table 178. ReachBio LLC Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 179. ReachBio LLC Primary Hepatocytes Product Portfolios and Specifications
Table 180. ReachBio LLC Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 181. ReachBio LLC Main Business
Table 182. ReachBio LLC Latest Developments
Table 183. AcceGen Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 184. AcceGen Primary Hepatocytes Product Portfolios and Specifications
Table 185. AcceGen Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 186. AcceGen Main Business
Table 187. AcceGen Latest Developments
Table 188. Sekisui XenoTech, LLC Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 189. Sekisui XenoTech, LLC Primary Hepatocytes Product Portfolios and Specifications
Table 190. Sekisui XenoTech, LLC Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 191. Sekisui XenoTech, LLC Main Business
Table 192. Sekisui XenoTech, LLC Latest Developments
Table 193. Biopredic International Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 194. Biopredic International Primary Hepatocytes Product Portfolios and Specifications
Table 195. Biopredic International Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 196. Biopredic International Main Business
Table 197. Biopredic International Latest Developments
Table 1. Primary Hepatocytes Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Primary Hepatocytes Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Human Primary Cells
Table 4. Major Players of Animal Primary Cells
Table 5. Global Primary Hepatocytes Sales by Type (2018-2023) & (K MT)
Table 6. Global Primary Hepatocytes Sales Market Share by Type (2018-2023)
Table 7. Global Primary Hepatocytes Revenue by Type (2018-2023) & ($ million)
Table 8. Global Primary Hepatocytes Revenue Market Share by Type (2018-2023)
Table 9. Global Primary Hepatocytes Sale Price by Type (2018-2023) & (USD/MT)
Table 10. Global Primary Hepatocytes Sales by Application (2018-2023) & (K MT)
Table 11. Global Primary Hepatocytes Sales Market Share by Application (2018-2023)
Table 12. Global Primary Hepatocytes Revenue by Application (2018-2023)
Table 13. Global Primary Hepatocytes Revenue Market Share by Application (2018-2023)
Table 14. Global Primary Hepatocytes Sale Price by Application (2018-2023) & (USD/MT)
Table 15. Global Primary Hepatocytes Sales by Company (2018-2023) & (K MT)
Table 16. Global Primary Hepatocytes Sales Market Share by Company (2018-2023)
Table 17. Global Primary Hepatocytes Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Primary Hepatocytes Revenue Market Share by Company (2018-2023)
Table 19. Global Primary Hepatocytes Sale Price by Company (2018-2023) & (USD/MT)
Table 20. Key Manufacturers Primary Hepatocytes Producing Area Distribution and Sales Area
Table 21. Players Primary Hepatocytes Products Offered
Table 22. Primary Hepatocytes Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Primary Hepatocytes Sales by Geographic Region (2018-2023) & (K MT)
Table 26. Global Primary Hepatocytes Sales Market Share Geographic Region (2018-2023)
Table 27. Global Primary Hepatocytes Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Primary Hepatocytes Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Primary Hepatocytes Sales by Country/Region (2018-2023) & (K MT)
Table 30. Global Primary Hepatocytes Sales Market Share by Country/Region (2018-2023)
Table 31. Global Primary Hepatocytes Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Primary Hepatocytes Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Primary Hepatocytes Sales by Country (2018-2023) & (K MT)
Table 34. Americas Primary Hepatocytes Sales Market Share by Country (2018-2023)
Table 35. Americas Primary Hepatocytes Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Primary Hepatocytes Revenue Market Share by Country (2018-2023)
Table 37. Americas Primary Hepatocytes Sales by Type (2018-2023) & (K MT)
Table 38. Americas Primary Hepatocytes Sales by Application (2018-2023) & (K MT)
Table 39. APAC Primary Hepatocytes Sales by Region (2018-2023) & (K MT)
Table 40. APAC Primary Hepatocytes Sales Market Share by Region (2018-2023)
Table 41. APAC Primary Hepatocytes Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Primary Hepatocytes Revenue Market Share by Region (2018-2023)
Table 43. APAC Primary Hepatocytes Sales by Type (2018-2023) & (K MT)
Table 44. APAC Primary Hepatocytes Sales by Application (2018-2023) & (K MT)
Table 45. Europe Primary Hepatocytes Sales by Country (2018-2023) & (K MT)
Table 46. Europe Primary Hepatocytes Sales Market Share by Country (2018-2023)
Table 47. Europe Primary Hepatocytes Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Primary Hepatocytes Revenue Market Share by Country (2018-2023)
Table 49. Europe Primary Hepatocytes Sales by Type (2018-2023) & (K MT)
Table 50. Europe Primary Hepatocytes Sales by Application (2018-2023) & (K MT)
Table 51. Middle East & Africa Primary Hepatocytes Sales by Country (2018-2023) & (K MT)
Table 52. Middle East & Africa Primary Hepatocytes Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Primary Hepatocytes Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Primary Hepatocytes Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Primary Hepatocytes Sales by Type (2018-2023) & (K MT)
Table 56. Middle East & Africa Primary Hepatocytes Sales by Application (2018-2023) & (K MT)
Table 57. Key Market Drivers & Growth Opportunities of Primary Hepatocytes
Table 58. Key Market Challenges & Risks of Primary Hepatocytes
Table 59. Key Industry Trends of Primary Hepatocytes
Table 60. Primary Hepatocytes Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Primary Hepatocytes Distributors List
Table 63. Primary Hepatocytes Customer List
Table 64. Global Primary Hepatocytes Sales Forecast by Region (2024-2029) & (K MT)
Table 65. Global Primary Hepatocytes Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Primary Hepatocytes Sales Forecast by Country (2024-2029) & (K MT)
Table 67. Americas Primary Hepatocytes Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Primary Hepatocytes Sales Forecast by Region (2024-2029) & (K MT)
Table 69. APAC Primary Hepatocytes Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Primary Hepatocytes Sales Forecast by Country (2024-2029) & (K MT)
Table 71. Europe Primary Hepatocytes Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Primary Hepatocytes Sales Forecast by Country (2024-2029) & (K MT)
Table 73. Middle East & Africa Primary Hepatocytes Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Primary Hepatocytes Sales Forecast by Type (2024-2029) & (K MT)
Table 75. Global Primary Hepatocytes Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Primary Hepatocytes Sales Forecast by Application (2024-2029) & (K MT)
Table 77. Global Primary Hepatocytes Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Thermo Fisher Scientific, Inc. Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 79. Thermo Fisher Scientific, Inc. Primary Hepatocytes Product Portfolios and Specifications
Table 80. Thermo Fisher Scientific, Inc. Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 81. Thermo Fisher Scientific, Inc. Main Business
Table 82. Thermo Fisher Scientific, Inc. Latest Developments
Table 83. Merck KGaA Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck KGaA Primary Hepatocytes Product Portfolios and Specifications
Table 85. Merck KGaA Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 86. Merck KGaA Main Business
Table 87. Merck KGaA Latest Developments
Table 88. Lonza Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 89. Lonza Primary Hepatocytes Product Portfolios and Specifications
Table 90. Lonza Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 91. Lonza Main Business
Table 92. Lonza Latest Developments
Table 93. Cell Biologics, Inc. Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 94. Cell Biologics, Inc. Primary Hepatocytes Product Portfolios and Specifications
Table 95. Cell Biologics, Inc. Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 96. Cell Biologics, Inc. Main Business
Table 97. Cell Biologics, Inc. Latest Developments
Table 98. PromoCell GmbH Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 99. PromoCell GmbH Primary Hepatocytes Product Portfolios and Specifications
Table 100. PromoCell GmbH Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 101. PromoCell GmbH Main Business
Table 102. PromoCell GmbH Latest Developments
Table 103. HemaCare Corporation Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 104. HemaCare Corporation Primary Hepatocytes Product Portfolios and Specifications
Table 105. HemaCare Corporation Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 106. HemaCare Corporation Main Business
Table 107. HemaCare Corporation Latest Developments
Table 108. ZenBio, Inc. Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 109. ZenBio, Inc. Primary Hepatocytes Product Portfolios and Specifications
Table 110. ZenBio, Inc. Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 111. ZenBio, Inc. Main Business
Table 112. ZenBio, Inc. Latest Developments
Table 113. STEMCELL Technologies, Inc. Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 114. STEMCELL Technologies, Inc. Primary Hepatocytes Product Portfolios and Specifications
Table 115. STEMCELL Technologies, Inc. Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 116. STEMCELL Technologies, Inc. Main Business
Table 117. STEMCELL Technologies, Inc. Latest Developments
Table 118. Corning Incorporated Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 119. Corning Incorporated Primary Hepatocytes Product Portfolios and Specifications
Table 120. Corning Incorporated Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 121. Corning Incorporated Main Business
Table 122. Corning Incorporated Latest Developments
Table 123. AllCells Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 124. AllCells Primary Hepatocytes Product Portfolios and Specifications
Table 125. AllCells Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 126. AllCells Main Business
Table 127. AllCells Latest Developments
Table 128. Axol Bioscience Ltd. Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 129. Axol Bioscience Ltd. Primary Hepatocytes Product Portfolios and Specifications
Table 130. Axol Bioscience Ltd. Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 131. Axol Bioscience Ltd. Main Business
Table 132. Axol Bioscience Ltd. Latest Developments
Table 133. iXCells Biotechnologies Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 134. iXCells Biotechnologies Primary Hepatocytes Product Portfolios and Specifications
Table 135. iXCells Biotechnologies Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 136. iXCells Biotechnologies Main Business
Table 137. iXCells Biotechnologies Latest Developments
Table 138. Neuromics Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 139. Neuromics Primary Hepatocytes Product Portfolios and Specifications
Table 140. Neuromics Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 141. Neuromics Main Business
Table 142. Neuromics Latest Developments
Table 143. StemExpress Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 144. StemExpress Primary Hepatocytes Product Portfolios and Specifications
Table 145. StemExpress Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 146. StemExpress Main Business
Table 147. StemExpress Latest Developments
Table 148. BioIVT Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 149. BioIVT Primary Hepatocytes Product Portfolios and Specifications
Table 150. BioIVT Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 151. BioIVT Main Business
Table 152. BioIVT Latest Developments
Table 153. ScienCell Research Laboratories, Inc. Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 154. ScienCell Research Laboratories, Inc. Primary Hepatocytes Product Portfolios and Specifications
Table 155. ScienCell Research Laboratories, Inc. Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 156. ScienCell Research Laboratories, Inc. Main Business
Table 157. ScienCell Research Laboratories, Inc. Latest Developments
Table 158. PPA Research Group, Inc. Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 159. PPA Research Group, Inc. Primary Hepatocytes Product Portfolios and Specifications
Table 160. PPA Research Group, Inc. Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 161. PPA Research Group, Inc. Main Business
Table 162. PPA Research Group, Inc. Latest Developments
Table 163. Creative Bioarray Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 164. Creative Bioarray Primary Hepatocytes Product Portfolios and Specifications
Table 165. Creative Bioarray Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 166. Creative Bioarray Main Business
Table 167. Creative Bioarray Latest Developments
Table 168. BPS Bioscience, Inc. Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 169. BPS Bioscience, Inc. Primary Hepatocytes Product Portfolios and Specifications
Table 170. BPS Bioscience, Inc. Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 171. BPS Bioscience, Inc. Main Business
Table 172. BPS Bioscience, Inc. Latest Developments
Table 173. Epithelix S?rl Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 174. Epithelix S?rl Primary Hepatocytes Product Portfolios and Specifications
Table 175. Epithelix S?rl Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 176. Epithelix S?rl Main Business
Table 177. Epithelix S?rl Latest Developments
Table 178. ReachBio LLC Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 179. ReachBio LLC Primary Hepatocytes Product Portfolios and Specifications
Table 180. ReachBio LLC Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 181. ReachBio LLC Main Business
Table 182. ReachBio LLC Latest Developments
Table 183. AcceGen Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 184. AcceGen Primary Hepatocytes Product Portfolios and Specifications
Table 185. AcceGen Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 186. AcceGen Main Business
Table 187. AcceGen Latest Developments
Table 188. Sekisui XenoTech, LLC Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 189. Sekisui XenoTech, LLC Primary Hepatocytes Product Portfolios and Specifications
Table 190. Sekisui XenoTech, LLC Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 191. Sekisui XenoTech, LLC Main Business
Table 192. Sekisui XenoTech, LLC Latest Developments
Table 193. Biopredic International Basic Information, Primary Hepatocytes Manufacturing Base, Sales Area and Its Competitors
Table 194. Biopredic International Primary Hepatocytes Product Portfolios and Specifications
Table 195. Biopredic International Primary Hepatocytes Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 196. Biopredic International Main Business
Table 197. Biopredic International Latest Developments
LIST OF FIGURES
Figure 1. Picture of Primary Hepatocytes
Figure 2. Primary Hepatocytes Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Primary Hepatocytes Sales Growth Rate 2018-2029 (K MT)
Figure 7. Global Primary Hepatocytes Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Primary Hepatocytes Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Human Primary Cells
Figure 10. Product Picture of Animal Primary Cells
Figure 11. Global Primary Hepatocytes Sales Market Share by Type in 2022
Figure 12. Global Primary Hepatocytes Revenue Market Share by Type (2018-2023)
Figure 13. Primary Hepatocytes Consumed in Life Science Research Companies
Figure 14. Global Primary Hepatocytes Market: Life Science Research Companies (2018-2023) & (K MT)
Figure 15. Primary Hepatocytes Consumed in Research Institutes
Figure 16. Global Primary Hepatocytes Market: Research Institutes (2018-2023) & (K MT)
Figure 17. Primary Hepatocytes Consumed in Others
Figure 18. Global Primary Hepatocytes Market: Others (2018-2023) & (K MT)
Figure 19. Global Primary Hepatocytes Sales Market Share by Application (2022)
Figure 20. Global Primary Hepatocytes Revenue Market Share by Application in 2022
Figure 21. Primary Hepatocytes Sales Market by Company in 2022 (K MT)
Figure 22. Global Primary Hepatocytes Sales Market Share by Company in 2022
Figure 23. Primary Hepatocytes Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Primary Hepatocytes Revenue Market Share by Company in 2022
Figure 25. Global Primary Hepatocytes Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Primary Hepatocytes Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Primary Hepatocytes Sales 2018-2023 (K MT)
Figure 28. Americas Primary Hepatocytes Revenue 2018-2023 ($ Millions)
Figure 29. APAC Primary Hepatocytes Sales 2018-2023 (K MT)
Figure 30. APAC Primary Hepatocytes Revenue 2018-2023 ($ Millions)
Figure 31. Europe Primary Hepatocytes Sales 2018-2023 (K MT)
Figure 32. Europe Primary Hepatocytes Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Primary Hepatocytes Sales 2018-2023 (K MT)
Figure 34. Middle East & Africa Primary Hepatocytes Revenue 2018-2023 ($ Millions)
Figure 35. Americas Primary Hepatocytes Sales Market Share by Country in 2022
Figure 36. Americas Primary Hepatocytes Revenue Market Share by Country in 2022
Figure 37. Americas Primary Hepatocytes Sales Market Share by Type (2018-2023)
Figure 38. Americas Primary Hepatocytes Sales Market Share by Application (2018-2023)
Figure 39. United States Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Primary Hepatocytes Sales Market Share by Region in 2022
Figure 44. APAC Primary Hepatocytes Revenue Market Share by Regions in 2022
Figure 45. APAC Primary Hepatocytes Sales Market Share by Type (2018-2023)
Figure 46. APAC Primary Hepatocytes Sales Market Share by Application (2018-2023)
Figure 47. China Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Primary Hepatocytes Sales Market Share by Country in 2022
Figure 55. Europe Primary Hepatocytes Revenue Market Share by Country in 2022
Figure 56. Europe Primary Hepatocytes Sales Market Share by Type (2018-2023)
Figure 57. Europe Primary Hepatocytes Sales Market Share by Application (2018-2023)
Figure 58. Germany Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Primary Hepatocytes Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Primary Hepatocytes Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Primary Hepatocytes Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Primary Hepatocytes Sales Market Share by Application (2018-2023)
Figure 67. Egypt Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Primary Hepatocytes in 2022
Figure 73. Manufacturing Process Analysis of Primary Hepatocytes
Figure 74. Industry Chain Structure of Primary Hepatocytes
Figure 75. Channels of Distribution
Figure 76. Global Primary Hepatocytes Sales Market Forecast by Region (2024-2029)
Figure 77. Global Primary Hepatocytes Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Primary Hepatocytes Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Primary Hepatocytes Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Primary Hepatocytes Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Primary Hepatocytes Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Primary Hepatocytes
Figure 2. Primary Hepatocytes Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Primary Hepatocytes Sales Growth Rate 2018-2029 (K MT)
Figure 7. Global Primary Hepatocytes Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Primary Hepatocytes Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Human Primary Cells
Figure 10. Product Picture of Animal Primary Cells
Figure 11. Global Primary Hepatocytes Sales Market Share by Type in 2022
Figure 12. Global Primary Hepatocytes Revenue Market Share by Type (2018-2023)
Figure 13. Primary Hepatocytes Consumed in Life Science Research Companies
Figure 14. Global Primary Hepatocytes Market: Life Science Research Companies (2018-2023) & (K MT)
Figure 15. Primary Hepatocytes Consumed in Research Institutes
Figure 16. Global Primary Hepatocytes Market: Research Institutes (2018-2023) & (K MT)
Figure 17. Primary Hepatocytes Consumed in Others
Figure 18. Global Primary Hepatocytes Market: Others (2018-2023) & (K MT)
Figure 19. Global Primary Hepatocytes Sales Market Share by Application (2022)
Figure 20. Global Primary Hepatocytes Revenue Market Share by Application in 2022
Figure 21. Primary Hepatocytes Sales Market by Company in 2022 (K MT)
Figure 22. Global Primary Hepatocytes Sales Market Share by Company in 2022
Figure 23. Primary Hepatocytes Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Primary Hepatocytes Revenue Market Share by Company in 2022
Figure 25. Global Primary Hepatocytes Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Primary Hepatocytes Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Primary Hepatocytes Sales 2018-2023 (K MT)
Figure 28. Americas Primary Hepatocytes Revenue 2018-2023 ($ Millions)
Figure 29. APAC Primary Hepatocytes Sales 2018-2023 (K MT)
Figure 30. APAC Primary Hepatocytes Revenue 2018-2023 ($ Millions)
Figure 31. Europe Primary Hepatocytes Sales 2018-2023 (K MT)
Figure 32. Europe Primary Hepatocytes Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Primary Hepatocytes Sales 2018-2023 (K MT)
Figure 34. Middle East & Africa Primary Hepatocytes Revenue 2018-2023 ($ Millions)
Figure 35. Americas Primary Hepatocytes Sales Market Share by Country in 2022
Figure 36. Americas Primary Hepatocytes Revenue Market Share by Country in 2022
Figure 37. Americas Primary Hepatocytes Sales Market Share by Type (2018-2023)
Figure 38. Americas Primary Hepatocytes Sales Market Share by Application (2018-2023)
Figure 39. United States Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Primary Hepatocytes Sales Market Share by Region in 2022
Figure 44. APAC Primary Hepatocytes Revenue Market Share by Regions in 2022
Figure 45. APAC Primary Hepatocytes Sales Market Share by Type (2018-2023)
Figure 46. APAC Primary Hepatocytes Sales Market Share by Application (2018-2023)
Figure 47. China Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Primary Hepatocytes Sales Market Share by Country in 2022
Figure 55. Europe Primary Hepatocytes Revenue Market Share by Country in 2022
Figure 56. Europe Primary Hepatocytes Sales Market Share by Type (2018-2023)
Figure 57. Europe Primary Hepatocytes Sales Market Share by Application (2018-2023)
Figure 58. Germany Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Primary Hepatocytes Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Primary Hepatocytes Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Primary Hepatocytes Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Primary Hepatocytes Sales Market Share by Application (2018-2023)
Figure 67. Egypt Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Primary Hepatocytes Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Primary Hepatocytes in 2022
Figure 73. Manufacturing Process Analysis of Primary Hepatocytes
Figure 74. Industry Chain Structure of Primary Hepatocytes
Figure 75. Channels of Distribution
Figure 76. Global Primary Hepatocytes Sales Market Forecast by Region (2024-2029)
Figure 77. Global Primary Hepatocytes Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Primary Hepatocytes Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Primary Hepatocytes Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Primary Hepatocytes Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Primary Hepatocytes Revenue Market Share Forecast by Application (2024-2029)
